| Product NDC: | 25021-140 |
| Proprietary Name: | Nafcillin |
| Non Proprietary Name: | nafcillin sodium |
| Active Ingredient(s): | 2 g/1 & nbsp; nafcillin sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-140 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090582 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121025 |
| Package NDC: | 25021-140-10 |
| Package Description: | 10 VIAL in 1 CARTON (25021-140-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| NDC Code | 25021-140-10 |
| Proprietary Name | Nafcillin |
| Package Description | 10 VIAL in 1 CARTON (25021-140-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 25021-140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nafcillin sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20121025 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | NAFCILLIN SODIUM |
| Strength Number | 2 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |